Microbiome Therapeutics Innovation Group

Acronym: MTIG

General Information

Identification Code: 816403444920-97

Website: https://microbiometig.org/

Entity Form: U.S. 501c6

Registration Category: Professional consultancies

Registration Date: 12/11/2021

Last Update: 11/1/2023

Mission & Interests

Goals: The Microbiome Therapeutics Innovation Group (MTIG) is an independent 501(c)(6) coalition of companies leading the research and development of FDA-approved microbiome therapeutics and microbiome-based products to address unmet medical needs, improve clinical outcomes, and reduce health care costs.

Interests Represented: Promotes their own interests or the collective interests of their members

Interests:

Public health

Levels of Interest:

global

Activities

Main EU Legislative Proposals: consultation for the revision of the general EU pharmaceutical legislation

Inter-institutional or Unofficial Groupings: N/A

Head Office

Address: 1001 Pennsylvania Ave. NWSuite 1300N

Post Code: 20003

City: Washington

Country: UNITED STATES

Phone:

Indic Phone: 1

Phone Number: 5705995560

EU Office

Address: 1001 Pennsylvania Ave. NWSuite 1300N

Post Code: 20003

City: Washington

Country: UNITED STATES

Phone:

Indic Phone: 1

Phone Number: 5705995560

Financial Data

Closed Year:

Start Date:

End Date:

Funding Sources:

Contributions:

Total Budget: 0

Grants:

Current Year:

Grants:

Complementary Information: The goal of MTIG's involvement in the E.U is to provide comment on the following consultation: https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/12963-Revision-of-the-EU-general-pharmaceuticals-legislation/public-consultation_en